Osteogenic stimulatory conditions enhance growth and maturation of endothelial cell microvascular networks in culture with mesenchymal stem cells

Journal of Tissue Engineering

Volumn 3, Issue 1, 2012, Pages 1-12

  Pedersen, Torbjorn O ^a,b   Blois, Anna L ^b   Xue, Ying ^a   Xing, Zhe ^a   Cottler Fox, Michele ^c   Fristad, Inge ^a   Leknes, Knut N ^a   Lorens, James B ^b   Mustafa, Kamal ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Endothelial cells; Mesenchymal stem cells; Microvascular networks; Osteogenesis

Indexed keywords

BLOOD VESSELS; BONE; ENDOTHELIAL CELLS; GENE EXPRESSION; MINERALOGY; STEM CELLS; TISSUE ENGINEERING;

CONDITION; CULTURE CONDITIONS; ENDOTHELIAL-CELLS; GENES EXPRESSION; IN-VITRO; MESENCHYMAL STEM CELL; MICROVASCULAR NETWORK; MINERALISATION; OSTEOGENESIS; OSTEOGENIC;

CELL CULTURE;

EID: 84875128048     PISSN: None     EISSN: 20417314     Source Type: Journal    
DOI: 10.1177/2041731412443236     Document Type: Article

References (51)

1. Arvidson K, Abdallah BM, Applegate LA, et al. Bone regeneration and stem cells. J Cell Mol Med 2011; 15: 718-746.
2. Lovett M, Lee K, Edwards A, et al. Vascularization strategies for tissue engineering. Tissue Eng Part B Rev 2009; 15: 353-370.
3. Novosel EC, Kleinhans C and Kluger PJ. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 2011; 63: 300-311.
4. Santos MI and Reis RL. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 2010; 10: 12-27.
5. Hegen A, Blois A, Tiron CE, et al. Efficient in vivo vascularization of tissue-engineering scaffolds. J Tissue Eng Regen Med 2011; 5: e52-e62.
6. Nor JE, Peters MC, Christensen JB, et al. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 2001; 81: 453-463.
7. Tremblay PL, Hudon V, Berthod F, et al. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 2005; 5: 1002-1010.
8. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003; 9: 685-693.
9. Lindskog H, Athley E, Larsson E, et al. New insights to vascular smooth muscle cell and pericyte differentiation of mouse embryonic stem cells in vitro. Arterioscler Thromb Vasc Biol 2006; 26: 1457-1464.
10. Benjamin LE, Hemo I and Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125: 1591-1598.
11. Saharinen P, Bry M and Alitalo K. How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 2010; 17: 198-205.
12. Au P, Tam J, Fukumura D, et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008; 111: 4551-4558.
13. Gruber R, Kandler B, Holzmann P, et al. Bone marrow stromal cells can provide a local environment that favors migration and formation of tubular structures of endothelial cells. Tissue Eng 2005; 11: 896-903.
14. Lozito TP, Kuo CK, Taboas JM, et al. Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J Cell Biochem 2009; 107: 714-722.
15. Xue Y, Xing Z, Hellem S, et al. Endothelial cells influence the osteogenic potential of bone marrow stromal cells. Biomed Eng Online 2009; 8: 34.
16. Kaigler D, Krebsbach PH, West ER, et al. Endothelial cell modulation of bone marrow stromal cell osteogenic potential. FASEB J 2005; 19: 665-667.
17. Grellier M, Bordenave L and Amedee J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 2009; 27: 562-571.
18. Ma J, van den Beucken JJ, Yang F, et al. Coculture of osteoblasts and endothelial cells: optimization of culture medium and cell ratio. Tissue Eng Part C Methods 2011; 17: 349-357.
19. Jaiswal N, Haynesworth SE, Caplan AI, et al. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997; 64: 295-312.
20. Swift S, Lorens J, Achacoso P., et al. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol 2001; Chapter 10: Unit 10 7C.
21. Evensen L, Micklem DR, Blois A, et al. Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 2009; 4: e5798.
22. Xing Z, Xue Y, Danmark S, et al. Effect of endothelial cells on bone regeneration using poly(l-lactide-co-1,5-dioxepan- 2-one) scaffolds. J Biomed Mater Res A 2010; 96: 349-357.
23. Bryan BA and D'Amore PA. Pericyte isolation and use in endothelial/pericyte coculture models. Methods Enzymol 2008; 443: 315-331.
24. Evensen L, Micklem DR, Link W, et al. A novel imagingbased high-throughput screening approach to anti-angiogenic drug discovery. Cytometry A 2010; 77: 41-51.
25. Hirschi KK, Rohovsky SA and D'Amore PA. PDGF, TGFbeta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141: 805-814.
26. Hayes AJ, Huang WQ, Mallah J, et al. Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 1999; 58: 224-237.
27. Saharinen P, Eklund L, Miettinen J, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 2008; 10: 527-537.
28. Fukuhara S, Sako K, Noda K, et al. Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 2010; 25: 387-396.
29. Gerhardt H. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 2008; 4: 241-246.
30. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-660.
31. Fiedler U and Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol 2006; 27: 552-558.
32. Thomas M and Augustin HG. The role of the angiopoietins in vascular morphogenesis. Angiogenesis 2009; 12: 125-137.
33. Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin- 1. Science 1999; 286: 2511-2514.
34. Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284: 1994-1998.
35. Olsson AK, Dimberg A, Kreuger J, et al. VEGF receptor signalling- in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-371.
36. Donovan D, Brown NJ, Bishop ET, et al. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 2001; 4: 113-121.
37. Villars F, Bordenave L, Bareille R, et al. Effect of human endothelial cells on human bone marrow stromal cell phenotype: role of VEGF? J Cell Biochem 2000; 79: 672-685.
38. Denis CV, Andre P, Saffaripour S, et al. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci U S A 2001; 98: 4072-4077.
39. Starke RD, Ferraro F, Paschalaki KE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011; 117: 1071-1080.
40. Chung CH, Golub EE, Forbes E, et al. Mechanism of action of beta-glycerophosphate on bone cell mineralization. Calcif Tissue Int 1992; 51: 305-311.
41. Choi KM, Seo YK, Yoon HH, et al. Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng 2008; 105: 586-594.
42. Yue BY, Niedra R and Baum JL. Effects of ascorbic acid on cultured rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci 1980; 19: 1471-1476.
43. Ek A, Strom K and Cotgreave IA. The uptake of ascorbic acid into human umbilical vein endothelial cells and its effect on oxidant insult. Biochem Pharmacol 1995; 50: 1339-1346.
44. Xiao Y, Peperzak V, van Rijn L, et al. Dexamethasone treatment during the expansion phase maintains stemness of bone marrow mesenchymal stem cells. J Tissue Eng Regen Med 2010; 4: 374-386.
45. Beloti MM and Rosa AL. Osteoblast differentiation of human bone marrow cells under continuous and discontinuous treatment with dexamethasone. Braz Dent J 2005; 16: 156-161.
46. Lian JB and Stein GS. Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med 1992; 3: 269-305.
47. Zhang JC, Kim S, Helmke BP, et al. Analysis of SM22alphadeficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol 2001; 21: 1336-1344.
48. Feng J, Mantesso A and Sharpe PT. Perivascular cells as mesenchymal stem cells. Expert Opin Biol Ther 2010; 10: 1441-1451.
49. Kaigler D, Krebsbach PH, Wang Z, et al. Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res 2006; 85: 633-637.
50. Unger RE, Sartoris A, Peters K, et al. Tissue-like selfassembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on threedimensional porous biomaterials. Biomaterials 2007; 28: 3965-3976.
51. Fuchs S, Jiang X, Schmidt H, et al. Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 2009; 30: 1329-1338.